Dialogues in Cardiovascular Medicine - Vol 5 . No. 1 . 2000



Diabetes and the Heart




R. Ferrari, D.J. Hearse




Reducing the impact of the diabetic heart’s increased vulnerability to cardiovascular disease
L. Rydén, K.A. Malmberg




What is the most effective management of hypertension in diabetes?
L.H. Opie


What is the most effective management of heart failure in diabetic patients?
A.P. Maggioni, G. Zuanetti


How can coronary artery disease and infarction be best managed in diabetics?
L.R. Benzaquen, R.W. Nesto




Surfing the Heart: European Society of Cardiology; Medscape® Cardiology; College and University Home Pages
C. Ceconi

Trails of Discovery: Paradigms of discovery in diabetes mellitus
A.M. Katz



D. Russell-Jones


Effects of an intravenous infusion of a potassium-glucose-insulin solution on the electrocardiographic signs of myocardial infarction
D. Sodi-Pallares and others

Diabetes and cardiovascular disease. The Framingham study
W.B. Kannel, D.L. McGee

Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study
J.H. Fuller and others

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
J. Stamler and others

NIDDM and its metabolic control predict coronary heart disease in elderly subjects
J. Kuusisto and others
Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience
S.L. Woodfield and others

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
K. Pyörälä and others

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
UK Prospective Diabetes Study Group

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38)
UK Prospective Diabetes Study Group

Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the DIGAMI study
K. Malmberg and others




© 2008 LES LABORATOIRES SERVIER, an incorporated company of SERVIER All Rights Reserved - Updates